A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Phase 2 Terminated
3 enrolled 12 charts
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Phase 2 Terminated
71 enrolled
BRIDGE
Phase 2 Terminated
10 enrolled
A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)
Phase 2 Terminated
36 enrolled 11 charts
ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Phase 2 Terminated
7 enrolled 10 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
CARMEN-LC05
Phase 2 Terminated
57 enrolled 26 charts
PRESERVE3
Phase 2 Terminated
92 enrolled 24 charts
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
25 enrolled
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
Phase 2 Terminated
2 enrolled
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Phase 2 Terminated
18 enrolled
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
Phase 2 Terminated
1 enrolled
Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
Phase 2 Terminated
2 enrolled 6 charts
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Phase 2 Terminated
4 enrolled 9 charts
Therapy De-escalation in Seminoma Stage IIA/B
Phase 2 Terminated
120 enrolled
A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Phase 2 Terminated
5 enrolled
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase 2 Terminated
6 enrolled 12 charts
Liver Directed RT + Chemo-immunotherapy for ES-SCLC
Phase 2 Terminated
2 enrolled 1 chart
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer
Phase 2 Terminated
6 enrolled 13 charts
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Terminated
23 enrolled 10 charts
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Phase 2 Terminated
17 enrolled 12 charts
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Phase 2 Terminated
3 enrolled 13 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Phase 2 Terminated
26 enrolled 11 charts
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Phase 2 Terminated
31 enrolled 8 charts
Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
Phase 2 Terminated
9 enrolled 4 charts
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Phase 2 Terminated
6 enrolled 18 charts
Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Phase 2 Terminated
7 enrolled 9 charts
Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer
Phase 2 Terminated
93 enrolled
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Phase 2 Terminated
4 enrolled 6 charts
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Phase 2 Terminated
7 enrolled 10 charts
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 8 charts
Genetic Predictors of Benefit to Pembrolizumab
Phase 2 Terminated
19 enrolled 12 charts
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
Phase 2 Terminated
17 enrolled 7 charts
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
Phase 2 Terminated
24 enrolled
KN046 in Patients With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
120 enrolled
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
30 enrolled 28 charts
Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
Phase 2 Terminated
148 enrolled 9 charts
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Phase 2 Terminated
7 enrolled 8 charts
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 2 Terminated
6 enrolled 9 charts
KEAPSAKE
Phase 2 Terminated
40 enrolled
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
Phase 2 Terminated
108 enrolled
GELATO
Phase 2 Terminated
23 enrolled
Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0
Phase 2 Terminated
3 enrolled 8 charts
DETECT
Phase 2 Terminated
12 enrolled
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
Phase 2 Terminated
102 enrolled 51 charts
IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
Phase 2 Terminated
11 enrolled 10 charts